QQQ   430.82 (-0.06%)
AAPL   169.07 (-2.10%)
MSFT   415.14 (+0.36%)
META   500.34 (+0.02%)
GOOGL   154.59 (-0.17%)
AMZN   183.27 (-0.19%)
TSLA   156.07 (-3.35%)
NVDA   873.26 (+1.54%)
AMD   162.84 (+1.57%)
NIO   3.86 (-0.77%)
BABA   69.92 (-0.99%)
T   15.98 (-1.60%)
F   12.12 (-0.90%)
MU   121.02 (-0.29%)
GE   155.42 (+1.12%)
CGC   6.80 (-2.58%)
DIS   113.68 (+0.65%)
AMC   2.80 (+13.36%)
PFE   25.74 (-0.66%)
PYPL   63.57 (+0.09%)
XOM   118.23 (-1.21%)
QQQ   430.82 (-0.06%)
AAPL   169.07 (-2.10%)
MSFT   415.14 (+0.36%)
META   500.34 (+0.02%)
GOOGL   154.59 (-0.17%)
AMZN   183.27 (-0.19%)
TSLA   156.07 (-3.35%)
NVDA   873.26 (+1.54%)
AMD   162.84 (+1.57%)
NIO   3.86 (-0.77%)
BABA   69.92 (-0.99%)
T   15.98 (-1.60%)
F   12.12 (-0.90%)
MU   121.02 (-0.29%)
GE   155.42 (+1.12%)
CGC   6.80 (-2.58%)
DIS   113.68 (+0.65%)
AMC   2.80 (+13.36%)
PFE   25.74 (-0.66%)
PYPL   63.57 (+0.09%)
XOM   118.23 (-1.21%)
QQQ   430.82 (-0.06%)
AAPL   169.07 (-2.10%)
MSFT   415.14 (+0.36%)
META   500.34 (+0.02%)
GOOGL   154.59 (-0.17%)
AMZN   183.27 (-0.19%)
TSLA   156.07 (-3.35%)
NVDA   873.26 (+1.54%)
AMD   162.84 (+1.57%)
NIO   3.86 (-0.77%)
BABA   69.92 (-0.99%)
T   15.98 (-1.60%)
F   12.12 (-0.90%)
MU   121.02 (-0.29%)
GE   155.42 (+1.12%)
CGC   6.80 (-2.58%)
DIS   113.68 (+0.65%)
AMC   2.80 (+13.36%)
PFE   25.74 (-0.66%)
PYPL   63.57 (+0.09%)
XOM   118.23 (-1.21%)
QQQ   430.82 (-0.06%)
AAPL   169.07 (-2.10%)
MSFT   415.14 (+0.36%)
META   500.34 (+0.02%)
GOOGL   154.59 (-0.17%)
AMZN   183.27 (-0.19%)
TSLA   156.07 (-3.35%)
NVDA   873.26 (+1.54%)
AMD   162.84 (+1.57%)
NIO   3.86 (-0.77%)
BABA   69.92 (-0.99%)
T   15.98 (-1.60%)
F   12.12 (-0.90%)
MU   121.02 (-0.29%)
GE   155.42 (+1.12%)
CGC   6.80 (-2.58%)
DIS   113.68 (+0.65%)
AMC   2.80 (+13.36%)
PFE   25.74 (-0.66%)
PYPL   63.57 (+0.09%)
XOM   118.23 (-1.21%)
Free Trial

Rocket Pharmaceuticals (RCKT) Earnings Date, Estimates & Call Transcripts

→ Can't believe it's happening again (From Manward Press) (Ad)
Free RCKT Stock Alerts
$24.21
+0.20 (+0.83%)
(As of 02:15 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
May. 2Estimated
Actual EPS
(Feb. 26)
-$0.64 Beat By $0.14
Consensus EPS
(Feb. 26)
-$0.78
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

RCKT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RCKT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Rocket Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.70)($0.49)($0.60)
Q2 20242($0.72)($0.49)($0.61)
Q3 20242($0.74)($0.48)($0.61)
Q4 20242($0.71)($0.47)($0.59)
FY 20248($2.87)($1.93)($2.40)
Q1 20251($0.47)($0.47)($0.47)
Q2 20251($0.34)($0.34)($0.34)
Q3 20251($0.32)($0.32)($0.32)
Q4 20251($0.23)($0.23)($0.23)
FY 20254($1.36)($1.36)($1.36)

RCKT Earnings Date and Information

Rocket Pharmaceuticals last announced its earnings results on February 26th, 2024. The biotechnology company reported ($0.64) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.78) by $0.14. Rocket Pharmaceuticals has generated ($2.94) earnings per share over the last year (($2.94) diluted earnings per share). Earnings for Rocket Pharmaceuticals are expected to grow in the coming year, from ($2.94) to ($1.91) per share. Rocket Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.

Rocket Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/2/2024
Estimated)		------- 
2/26/2024Q4 2023($0.78)($0.64)+$0.14($0.64)--
11/6/2023Q3 2023($0.81)($0.75)+$0.06($0.75)--
8/10/2023Q2 2023($0.81)($0.82)($0.01)($0.82)--
5/4/2023Q1 2023($0.84)($0.73)+$0.11($0.73)--
2/27/2023Q4 2022($0.82)($0.92)($0.10)($0.92)--
11/3/2022Q3 2022($0.77)($0.87)($0.10)($0.87)--
8/8/2022Q2 2022($0.68)($0.83)($0.15)($0.83)--
5/5/2022Q1 2022($0.70)($0.67)+$0.03($0.67)--
2/24/2022Q4 2021($0.75)($0.69)+$0.06($0.69)--    
11/3/2021Q3 2021($0.60)($0.79)($0.19)($0.79)--
8/9/2021Q2 2021($0.66)($0.55)+$0.11($0.55)--    
5/10/2021Q1 2021($0.69)($0.65)+$0.04($0.65)--

Rocket Pharmaceuticals Earnings - Frequently Asked Questions

When is Rocket Pharmaceuticals's earnings date?

Rocket Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on RCKT's earnings history.

Did Rocket Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Rocket Pharmaceuticals (NASDAQ:RCKT) reported ($0.64) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.78) by $0.14. Learn more on analysts' earnings estimate vs. RCKT's actual earnings.

How much profit does Rocket Pharmaceuticals generate each year?

Rocket Pharmaceuticals (NASDAQ:RCKT) has a recorded net income of -$245.60 million. RCKT has generated -$2.94 earnings per share over the last four quarters.

What is Rocket Pharmaceuticals's EPS forecast for next year?

Rocket Pharmaceuticals's earnings are expected to grow from ($2.94) per share to ($1.91) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:RCKT) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Can't believe it's happening again
Manward Press
He Is Giving Away Bitcoin
Crypto Swap Profits
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Options trading has suddenly become more reliable.
Eagle Publishing
A.I. Pioneer Issues Urgent Warning to Americans
TradeSmith